Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA5 | O75582 | 3/20 | 0.60 |
| ▸ | CDC7 | O00311 | 1/20 | 0.54 |
| ▸ | CDK2 | P24941 | 1/20 | 0.54 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.54 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.48 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | PRKCG | P05129 | 1/20 | 0.47 |
| ▸ | PRKCB | P05771 | 1/20 | 0.47 |
| ▸ | PRKCA | P17252 | 1/20 | 0.47 |
| ▸ | PRKACA | P17612 | 1/20 | 0.47 |
| ▸ | PRKACG | P22612 | 1/20 | 0.47 |
| ▸ | PRKACB | P22694 | 1/20 | 0.47 |
| ▸ | PRKCH | P24723 | 1/20 | 0.47 |
| ▸ | PRKCI | P41743 | 1/20 | 0.47 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.47 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.47 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.47 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.47 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29388240 | 1.00 | RPS6KA5 (0.60) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL13052919 | 0.85 | BIRC5 (0.59) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL28389224 | 0.84 | CDC7 (0.47) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL18803631 | 0.82 | MKNK1 (0.60) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL29975548 | 0.81 | CDC7 (0.45) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL524138 | 0.80 | CDC7 (0.60) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL29388549 | 0.80 | CDC7 (0.60) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL31107087 | 0.80 | CDC7 (0.60) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL7867877 | 0.78 | CDC7 (0.47) | RPS6KA5CDC7CDK2ROCK1BIRC5 | |
| SCHEMBL23559754 | 0.77 | CDC7 (0.42) | RPS6KA5CDC7CDK2ROCK1BIRC5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116288422-A | Method for realizing 2-position alkylation of indole by utilizing micro-channel photoelectrocatalysis technology and product | 南京工业大学 | 2023-06-23 | — | — | CN | claimed |
| CN-109678810-B | 1,2-oxygen nitrogen heterocyclic butane compound and preparation method and application thereof | 南京工业大学 | 2022-10-28 | — | — | CN | claimed |
| CN-110563701-B | N-2-pyrimidine-2-azido-3- (2,2,6, 6-tetramethylpiperidinyloxy) indoline and preparation and application thereof | 浙江工业大学 | 2022-09-16 | — | — | CN | claimed |
| CN-112574180-B | N-2-pyrimidinyl-3-fluoroindole compound and preparation method and application thereof | 浙江工业大学 | 2021-10-15 | — | — | CN | claimed |
| CN-111039927-B | Method for synthesizing beta-aryl ketone at room temperature by using reusable catalytic system | 陕西科技大学 | 2021-04-13 | — | — | CN | claimed |
| CN-112574180-A | N-2-pyrimidinyl-3-fluoroindole compound and preparation method and application thereof | 浙江工业大学 | 2021-03-30 | — | — | CN | claimed |
| US-10940468-B2 | Nickel catalyst, process for preparation and use thereof | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2021-03-09 | — | — | US | claimed |
| CN-111039927-A | Method for synthesizing β -aryl ketone at room temperature by using reusable catalytic system | 陕西科技大学 | 2020-04-21 | — | — | CN | claimed |
| CN-106279236-B | Method for synthesizing 2-triisopropyl silicon-based acetylene indole compound | 南京理工大学 | 2020-04-10 | — | — | CN | claimed |
| CN-110563701-A | N-2-pyrimidine-2-azido-3- (2,2,6, 6-tetramethylpiperidinyloxy) indoline and preparation and application thereof | 浙江工业大学 | 2019-12-13 | — | — | CN | claimed |
| WO-2017154022-A1 | NOVEL NICKEL CATALYST, PROCESS FOR PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2017-09-14 | — | — | WO | claimed |
| CN-101257948-A | Pyrimidine-fused diazepine derivatives and indole-fused pteridines | ATTENUON LLC (US) | 2008-09-03 | — | — | CN | claimed |
| US-20260015332-A1 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | GUANGZHOU MEDICAL UNIVERSITY (CN) | 2026-01-15 | — | — | US | disclosed |
| US-11935803-B2 | Resin composition, laminate, semiconductor wafer with resin composition layer, substrate for mounting semiconductor with resin composition layer and semiconductor device | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2024-03-19 | — | — | US | disclosed |
| WO-2023169082-A1 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIADIAZOLE-1-KETONE COMPOUND AND DERIVATIVE THEREOF | 广州医科大学 | 2023-09-14 | — | — | WO | disclosed |
| CN-116514781-A | Fluorescent dye with alkenyl indole as parent nucleus and preparation and application thereof | 温州医科大学附属第一医院 | 2023-08-01 | — | — | CN | disclosed |
| WO-2015089218-A1 | MONOCYCLIC PYRIMIDINE/PYRIDINE COMPOUNDS AS INHIBITORS OF P97 COMPLEX | WUSTROW DAVID (US) | 2015-06-18 | — | — | WO | disclosed |
| EP-2563774-A1 | PYRIMIDINYL INDOLE COMPOUNDS | Hutchison Medipharma Limited (CN) | 2013-03-06 | — | — | EP | disclosed |
| WO-2011134140-A1 | PYRIMIDINYL INDOLE COMPOUNDS | HUTCHISON MEDIPHARMA LIMITED (CN) | 2011-11-03 | — | — | WO | disclosed |
| CN-101257948-A | Pyrimidine-fused diazepine derivatives and indole-fused pteridines | ATTENUON LLC (US) | 2008-09-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10940468-B2 | Nickel catalyst, process for preparation and use thereof | NISCH, NIT2, C9 | RPS6KA5 3540/4885CDC7 1430/4885CDK2 2978/4885 |
| US-20260015332-A1 | SYNTHESIS METHOD AND APPLICATION OF BENZOTHIASELENAZOLE-1-OXIDE COMPOUND AND DERIVATIVE THEREOF | SARS1, EGFR, ERBB2 | RPS6KA5 1460/4885CDC7 2360/4885CDK2 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.